Literature DB >> 27867981

Grazoprevir plus elbasvir and other treatment options in hepatitis C infected patients with stage 4-5 chronic kidney disease.

Kalyan Ram Bhamidimarri1.   

Abstract

Entities:  

Year:  2016        PMID： 27867981      PMCID： PMC5104624          DOI： 10.21037/atm.2016.10.41

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  18 in total

Review 1.  Hepatitis C in hemodialysis patients.

Authors:  Smaragdi Marinaki; John N Boletis; Stratigoula Sakellariou; Ioanna K Delladetsima
Journal:  World J Hepatol       Date:  2015-03-27

Review 2.  Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Authors: 
Journal:  Hepatology       Date:  2015-08-04       Impact factor: 17.425

3.  Finally, safe and effective treatment options for hepatitis C in hemodialysis patients.

Authors:  Kalyan Ram Bhamidimarri; Paul Martin
Journal:  J Hepatol       Date:  2016-04-09       Impact factor: 25.083

4.  Shorter waitlist times and improved graft survivals are observed in patients who accept hepatitis C virus+ renal allografts.

Authors:  Joseph R Scalea; Rolf N Barth; Raghava Munivenkatappa; Benjamin Philosophe; Matthew Cooper; Victoria Whitlow; John C LaMattina
Journal:  Transplantation       Date:  2015-06       Impact factor: 4.939

5.  Efficacy of Direct-Acting Antiviral Combination for Patients With Hepatitis C Virus Genotype 1 Infection and Severe Renal Impairment or End-Stage Renal Disease.

Authors:  Paul J Pockros; K Rajender Reddy; Parvez S Mantry; Eric Cohen; Michael Bennett; Mark S Sulkowski; David E Bernstein; Daniel E Cohen; Nancy S Shulman; Deli Wang; Amit Khatri; Manal Abunimeh; Thomas Podsadecki; Eric Lawitz
Journal:  Gastroenterology       Date:  2016-03-11       Impact factor: 22.682

Review 6.  Hepatitis C virus infection in haemodialysis and kidney transplant patients.

Authors:  Seema Baid-Agrawal; Manuel Pascual; Darius Moradpour; Ulrich Frei; Nina Tolkoff-Rubin
Journal:  Rev Med Virol       Date:  2008 Mar-Apr       Impact factor: 6.989

Review 7.  Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality?

Authors:  F Fabrizi; V Dixit; P Messa
Journal:  J Viral Hepat       Date:  2012-07-17       Impact factor: 3.728

Review 8.  Hepatitis C virus and nonliver solid organ transplantation.

Authors:  Marco Carbone; David Mutimer; James Neuberger
Journal:  Transplantation       Date:  2013-03-27       Impact factor: 4.939

9.  Efficacy and Safety of Sofosbuvir-Based Antiviral Therapy to Treat Hepatitis C Virus Infection After Kidney Transplantation.

Authors:  N Kamar; O Marion; L Rostaing; O Cointault; D Ribes; L Lavayssière; L Esposito; A Del Bello; S Métivier; K Barange; J Izopet; L Alric
Journal:  Am J Transplant       Date:  2015-11-20       Impact factor: 8.086

10.  Grazoprevir-Elbasvir Combination Therapy for Treatment-Naive Cirrhotic and Noncirrhotic Patients With Chronic Hepatitis C Virus Genotype 1, 4, or 6 Infection: A Randomized Trial.

Authors:  Stefan Zeuzem; Reem Ghalib; K Rajender Reddy; Paul J Pockros; Ziv Ben Ari; Yue Zhao; Deborah D Brown; Shuyan Wan; Mark J DiNubile; Bach-Yen Nguyen; Michael N Robertson; Janice Wahl; Eliav Barr; Joan R Butterton
Journal:  Ann Intern Med       Date:  2015-07-07       Impact factor: 51.598
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.